A. Jemal, R. Siegel, and E. Ward, Cancer Statistics, 2009, CA: A Cancer Journal for Clinicians, vol.59, issue.4, pp.225-249, 2009.
DOI : 10.3322/caac.20006

M. Kattan, T. Wheeler, and P. Scardino, Postoperative Nomogram for Disease Recurrence After Radical Prostatectomy for Prostate Cancer, Journal of Clinical Oncology, vol.17, issue.5, pp.1499-1507
DOI : 10.1200/JCO.1999.17.5.1499

K. Roehl, M. Han, C. Ramos, J. Antenor, and W. Catalona, CANCER PROGRESSION AND SURVIVAL RATES FOLLOWING ANATOMICAL RADICAL RETROPUBIC PROSTATECTOMY IN 3,478 CONSECUTIVE PATIENTS: LONG-TERM RESULTS, The Journal of Urology, vol.172, issue.3, pp.910-914, 2004.
DOI : 10.1097/01.ju.0000134888.22332.bb

D. Amico, A. Whittington, R. Malkowicz, and S. , Biochemical Outcome After Radical Prostatectomy, External Beam Radiation Therapy, or Interstitial Radiation Therapy for Clinically Localized Prostate Cancer, JAMA, vol.280, issue.11, pp.969-974, 1998.
DOI : 10.1001/jama.280.11.969

E. M. Messing, J. Manola, and J. Yao, Immediate versus deferred androgen deprivation treatment in patients with node-positive prostate cancer after radical prostatectomy and pelvic lymphadenectomy, The Lancet Oncology, vol.7, issue.6, pp.472-479, 2006.
DOI : 10.1016/S1470-2045(06)70700-8

L. Klotz, S. Goldenberg, and M. Jewett, Long-term Followup of a Randomized Trial of 0 Versus 3 Months of Neoadjuvant Androgen Ablation Before Radical Prostatectomy, The Journal of Urology, vol.170, issue.3, pp.791-794, 2003.
DOI : 10.1097/01.ju.0000081404.98273.fd

I. Thompson, C. Tangen, and J. Paradelo, Adjuvant Radiotherapy for Pathological T3N0M0 Prostate Cancer Significantly Reduces Risk of Metastases and Improves Survival: Long-Term Followup of a Randomized Clinical Trial, The Journal of Urology, vol.181, issue.3, pp.956-62, 2009.
DOI : 10.1016/j.juro.2008.11.032

D. Petrylak, C. Tangen, and M. Hussain, Docetaxel and Estramustine Compared with Mitoxantrone and Prednisone for Advanced Refractory Prostate Cancer, New England Journal of Medicine, vol.351, issue.15
DOI : 10.1056/NEJMoa041318

I. Tannock, R. De-wit, and W. Berry, Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer, New England Journal of Medicine, vol.351, issue.15, pp.1502-1512, 2004.
DOI : 10.1056/NEJMoa040720

A. S. Kibel, E. Rosenbaum, and M. W. Kattan, Adjuvant Weekly Docetaxel for Patients With High Risk Prostate Cancer After Radical Prostatectomy: A Multi-Institutional Pilot Study, The Journal of Urology, vol.177, issue.5, pp.1777-1781, 2007.
DOI : 10.1016/j.juro.2007.01.028

J. Cetnar, S. Malkowicz, S. Palmer, A. Wein, and D. Vaughn, Pilot Trial of Adjuvant Paclitaxel Plus Estramustine in Resected High-Risk Prostate Cancer, Urology, vol.71, issue.5, pp.942-946, 2008.
DOI : 10.1016/j.urology.2007.11.117

B. Montgomery, P. Lavori, and M. Garzotto, Veterans Affairs Cooperative Studies Program Study 553: Chemotherapy After Prostatectomy, a Phase III Randomized Study of Prostatectomy Versus Prostatectomy with Adjuvant Docetaxel for Patients with High-Risk, Localized Prostate Cancer, Urology, vol.72, issue.3, pp.474-80, 2008.
DOI : 10.1016/j.urology.2008.02.050

G. Sonpavde, K. Chi, and T. Powles, Neoadjuvant therapy followed by prostatectomy for clinically localized prostate cancer Phase II trial of neoadjuvant docetaxel before radical prostatectomy for locally advanced prostate cancer, Cancer Urology, vol.1101663, pp.2628-391138, 2004.

P. Febbo, J. Richie, and D. George, Neoadjuvant Docetaxel before Radical Prostatectomy in Patients with High-Risk Localized Prostate Cancer, Clinical Cancer Research, vol.11, issue.14, pp.5233-5273, 2004.
DOI : 10.1158/1078-0432.CCR-05-0299

I. Thompson, C. Tangen, and J. Paradelo, Adjuvant Radiotherapy for Pathologically Advanced Prostate Cancer, JAMA, vol.296, issue.19, pp.2329-2364, 2006.
DOI : 10.1001/jama.296.19.2329

M. Sokoloff, C. Rinker-schaeffer, L. Chung, and C. Brendler, ADJUNCTIVE THERAPY FOR MEN WITH HIGH RISK LOCALIZED AND LOCALLY ADVANCED PROSTATE CANCER: TARGETING DISSEMINATED TUMOR CELLS, The Journal of Urology, vol.172, issue.6, pp.004604812539-44, 2004.
DOI : 10.1097/01.ju.0000145044.97177.09

B. J. Roth, B. Y. Yeap, G. Wilding, B. Kasimis, D. Mcleod et al., Taxol in advanced, hormone-refractory carcinoma of the prostate. A phase II trial of the eastern cooperative oncology group, Cancer, vol.12, issue.8, pp.2457-2460, 1993.
DOI : 10.1002/1097-0142(19931015)72:8<2457::AID-CNCR2820720825>3.0.CO;2-Z

C. Trivedi, B. Redman, and L. E. Flaherty, Weekly 1-hour infusion of paclitaxel, Cancer, vol.13, issue.2, pp.431-436, 2000.
DOI : 10.1002/1097-0142(20000715)89:2<431::AID-CNCR31>3.0.CO;2-B

L. Salomon, A. Anastasiadis, and R. Katz, Urinary Continence and Erectile Function: A Prospective Evaluation of Functional Results after Radical Laparoscopic Prostatectomy, European Urology, vol.42, issue.4, pp.338-343, 2002.
DOI : 10.1016/S0302-2838(02)00360-3

L. Salomon, F. Saint, A. Anastasiadis, P. Sèbe, D. Chopin et al., Combined Reporting of Cancer Control and Functional Results of Radical Prostatectomy, European Urology, vol.44, issue.6, pp.656-660, 2003.
DOI : 10.1016/j.eururo.2003.09.009